Harbor Investment Advisory LLC Decreases Stake in iShares Biotechnology ETF (NASDAQ:IBB)

Harbor Investment Advisory LLC lowered its position in iShares Biotechnology ETF (NASDAQ:IBB) by 15.4% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 1,704 shares of the financial services provider’s stock after selling 311 shares during the period. Harbor Investment Advisory LLC’s holdings in iShares Biotechnology ETF were worth $225,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. PVG Asset Management Corp purchased a new position in iShares Biotechnology ETF in the 2nd quarter valued at $415,000. Huntington National Bank lifted its holdings in iShares Biotechnology ETF by 17.9% in the 3rd quarter. Huntington National Bank now owns 1,054 shares of the financial services provider’s stock valued at $153,000 after purchasing an additional 160 shares in the last quarter. National Bank of Canada FI lifted its holdings in iShares Biotechnology ETF by 5.9% in the 3rd quarter. National Bank of Canada FI now owns 4,124 shares of the financial services provider’s stock valued at $600,000 after purchasing an additional 229 shares in the last quarter. First Financial Bank Trust Division purchased a new position in iShares Biotechnology ETF in the 3rd quarter valued at $204,000. Finally, Thrive Wealth Management LLC purchased a new position in iShares Biotechnology ETF in the 3rd quarter valued at $445,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of IBB stock opened at $136.29 on Thursday. iShares Biotechnology ETF has a fifty-two week low of $123.60 and a fifty-two week high of $150.57. The stock’s fifty day moving average is $136.00 and its two-hundred day moving average is $141.81.

iShares Biotechnology ETF Cuts Dividend

The business also recently declared a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were issued a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.